Researsh Progress of Antiepileptic Drugs in Pregnant Women and Pharmaceutical Care

Women with epilepsy of childbearing age, when receiving anti epileptic treatment, will be confronted with a series of important reproductive health problems. First, the disease and drug treatment may affect the female reproductive hormone secretion, resulting in decreased ability to conceive. Second, antiepileptic drugs have teratogenic risks to the fetus; Third, seizures in pregnancy will increase maternal mortality and obstetric complications. This paper will focus on the research progress of the anti epileptic management of pregnant women in recent years.